Dexcom Inc (NASDAQ: DXCM) is -9.07% lower on its value in year-to-date trading and has touched a low of $62.34 and a high of $142.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DXCM stock was last observed hovering at around $77.84 in the last trading session, with the day’s loss setting it -7.12%.
Currently trading at $70.72, the stock is -17.46% and -16.25% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.34 million and changing -9.15% at the moment leaves the stock -16.87% off its SMA200. DXCM registered -47.11% loss for a year compared to 6-month gain of 2.42%.
The stock witnessed a -19.93% loss in the last 1 month and extending the period to 3 months gives it a -12.70%, and is -17.76% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.42% over the week and 3.27% over the month.
Dexcom Inc (DXCM) has around 10300 employees, a market worth around $27.64B and $4.03B in sales. Current P/E ratio is 49.64 and Fwd P/E is 28.58. Profit margin for the company is 14.29%. Distance from 52-week low is 13.44% and -50.20% from its 52-week high. The company has generated returns on investments over the last 12 months (16.64%).
with sales reaching $1.02B over the same period.The EPS is expected to grow by 23.15% this year, but quarterly earnings will post 14.09% year-over-year. Quarterly sales are estimated to grow 10.44% in year-over-year returns.
Dexcom Inc (DXCM) Top Institutional Holders
The shares outstanding are 390.70M, and float is at 385.48M with Short Float at 2.46%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 46.51 million shares valued at $5.27 billion. The investor’s holdings represent 11.9203% of the DXCM Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 34.52 million shares valued at $3.91 billion to account for 8.8466 of the shares outstanding. The other top investors are STATE STREET CORP which holds 16.31 million shares representing 4.0853% and valued at over $1.85 billion, while BAILLIE GIFFORD & CO holds 3.8392 of the shares totaling 15.33 million with a market value of $1.74 billion.
Dexcom Inc (DXCM) Insider Activity
#####
Dexcom Inc disclosed in a document filed with the SEC on Jan 29 ’25 that Sylvain Jereme M (EVP, Chief Financal Officer) sold a total of 2,090 shares of the company’s common stock. The trade occurred on Jan 29 ’25 and was made at $86.91 per share for $0.18 million. Following the transaction, the insider now directly holds 83526.0 shares of the DXCM stock.
Still, SEC filings show that on Jan 29 ’25, Dolan Matthew Vincent (EVP, Strategy & Corporate Dev) disposed off 1,183 shares at an average price of $86.91 for $0.1 million. The insider now directly holds 42,044 shares of Dexcom Inc (DXCM).
